Compare $ENOV vs $IART | Chartloom

Compare

$ENOV vs $IART

Enovis Corp · Integra Lifesciences Holdings Corp

ENOV

Enovis Corp

IART

Integra Lifesciences Holdings Corp

Compare $ENOV vs $IART

Comparing Enovis Corp and Integra Lifesciences Holdings Corp

ENOVEnovis Corp

IARTIntegra Lifesciences Holdings Corp

ENOVEnovis Corp

Market cap

$1.02B

P/E (TTM)

—

Forward P/E (NTM)

4.57x

Forward P/S (NTM)

0.41x

Rev growth (TTM)

4.9%

YTD performance

-33.3%

52W performance

-44.3%

FCF yield

6.3%

IARTIntegra Lifesciences Holdings Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

4.99x

Forward P/S (NTM)

0.60x

Rev growth (TTM)

0.8%

YTD performance

11.9%

52W performance

-9.3%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENOV

IART

Detailed metrics comparison

ENOV

Enovis Corp

IART

Integra Lifesciences Holdings Corp

Market Cap

ENOV$1.02B

IART$1.05B

Enterprise Value

ENOV$2.29B

IART$1.05B

Price

ENOV$17.69

IART$13.44

P/E Ratio

ENOVN/A

IARTN/A

P/S Ratio

ENOV0.44x

IART0.63x

EV/Sales

ENOV1.00x

IART0.63x

EV/EBITDA

ENOV5.92x

IART3.92x

P/B Ratio

ENOV0.69x

IART0.95x

P/FCF Ratio

ENOV16.00x

IARTN/A

EV/FCF

ENOV35.98x

IART-73.87x

PEG Ratio

ENOVN/A

IARTN/A

Forward P/E (NTM)

ENOV4.57x

IART4.99x

Forward P/S (NTM)

ENOV0.41x

IART0.60x

Revenue (TTM)

ENOV$2.30B

IART$1.66B

Revenue Growth (YoY)

ENOV4.9%

IART0.8%

Forward Rev Growth

ENOV4.9%

IART3.2%

Gross Margin (TTM)

ENOV61.4%

IART43.1%

Operating Margin (TTM)

ENOV0.0%

IART4.0%

EBITDA Margin (TTM)

ENOV16.9%

IART16.1%

Net Margin (TTM)

ENOV-48.0%

IART-0.1%

FCF Margin (TTM)

ENOV2.8%

IART-0.9%

Net Income (TTM)

ENOV$-1.10B

IART$-2M

FCF (TTM)

ENOV$64M

IART$-14M

EPS (TTM)

ENOV-$19.13

IART$0.00

ROE (TTM)

ENOV-6817.0%

IART-70.0%

ROA (TTM)

ENOV-2777.0%

IART-20.0%

ROIC (TTM)

ENOV-3756.0%

IART-25.0%

Cash

ENOV$13M

IART$0

Debt

ENOV$1.28B

IART$0

Net Cash/Debt

ENOV$-1.27B

IART$0

Current Ratio (TTM)

ENOV1.98x

IART3.60x

Quick Ratio (TTM)

ENOV0.92x

IART1.80x

Debt/Equity (TTM)

ENOV0.87x

IART1.79x

Debt/Assets (TTM)

ENOV0.0%

IART0.0%

Interest Coverage (TTM)

ENOVN/A

IARTN/A

Net Debt/EBITDA (TTM)

ENOV0.00x

IART0.00x

Beta

ENOV1.45

IART1.27

52W Performance

ENOV-44.3%

IART-9.3%

YTD Performance

ENOV-33.3%

IART11.9%

% from 52W High

ENOV-48.4%

IART-34.4%

% from 52W Low

ENOV5.9%

IART54.5%

Asset Turnover (TTM)

ENOV0.58x

IART0.46x

FCF Yield (TTM)

ENOV6.3%

IART-1.4%

Earnings Yield (TTM)

ENOV-108.2%

IART-0.2%

Dividend Yield (TTM)

ENOVN/A

IARTN/A

Rule of 40

ENOV7.7

IART-0.0

EV/GP/RG

ENOV0.19

IART0.26

Ticker research

View ENOV research View IART research

Metric	ENOV Enovis Corp	IART Integra Lifesciences Holdings Corp
Market & Valuation
Market Cap	$1.02B	$1.05B
Enterprise Value	$2.29B	$1.05B
Price	$17.69	$13.44
P/E Ratio	N/A	N/A
P/S Ratio	0.44x	0.63x
EV/Sales	1.00x	0.63x
EV/EBITDA	5.92x	3.92x
P/B Ratio	0.69x	0.95x
P/FCF Ratio	16.00x	N/A
EV/FCF	35.98x	-73.87x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.57x	4.99x
Forward P/S (NTM)	0.41x	0.60x
Revenue & Growth
Revenue (TTM)	$2.30B	$1.66B
Revenue Growth (YoY)	4.9%	0.8%
Forward Rev Growth	4.9%	3.2%
Profitability
Gross Margin (TTM)	61.4%	43.1%
Operating Margin (TTM)	0.0%	4.0%
EBITDA Margin (TTM)	16.9%	16.1%
Net Margin (TTM)	-48.0%	-0.1%
FCF Margin (TTM)	2.8%	-0.9%
Net Income (TTM)	$-1.10B	$-2M
FCF (TTM)	$64M	$-14M
EPS (TTM)	-$19.13	$0.00
ROE (TTM)	-6817.0%	-70.0%
ROA (TTM)	-2777.0%	-20.0%
ROIC (TTM)	-3756.0%	-25.0%
Financial Health
Cash	$13M	$0
Debt	$1.28B	$0
Net Cash/Debt	$-1.27B	$0
Current Ratio (TTM)	1.98x	3.60x
Quick Ratio (TTM)	0.92x	1.80x
Debt/Equity (TTM)	0.87x	1.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.27
52W Performance	-44.3%	-9.3%
YTD Performance	-33.3%	11.9%
% from 52W High	-48.4%	-34.4%
% from 52W Low	5.9%	54.5%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.46x
FCF Yield (TTM)	6.3%	-1.4%
Earnings Yield (TTM)	-108.2%	-0.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.7	-0.0
EV/GP/RG	0.19	0.26
Ticker research	View ENOV research	View IART research

Valuation

P/S Ratio

ENOV

0.44x

IART

0.63x

EV/FCF

IART

-73.87x

ENOV

35.98x

Growth & revenue

Revenue Growth TTM

ENOV

4.9%

IART

0.8%

Forward Revenue Growth

ENOV

4.9%

IART

3.2%

Profitability & performance

Gross Margin

ENOV

61.4%

IART

43.1%

ROE

IART

-70.0%

ENOV

-6817.0%

FCF Yield %

ENOV

6.3%

IART

-1.4%

52-Week Performance

IART

-9.3%

ENOV

-44.3%

Detailed metrics comparison

ENOV

Enovis Corp

IART

Integra Lifesciences Holdings Corp

Market Cap

ENOV$1.02B

IART$1.05B

Enterprise Value

ENOV$2.29B

IART$1.05B

Price

ENOV$17.69

IART$13.44

P/E Ratio

ENOVN/A

IARTN/A

P/S Ratio

ENOV0.44x

IART0.63x

EV/Sales

ENOV1.00x

IART0.63x

EV/EBITDA

ENOV5.92x

IART3.92x

P/B Ratio

ENOV0.69x

IART0.95x

P/FCF Ratio

ENOV16.00x

IARTN/A

EV/FCF

ENOV35.98x

IART-73.87x

PEG Ratio

ENOVN/A

IARTN/A

Forward P/E (NTM)

ENOV4.57x

IART4.99x

Forward P/S (NTM)

ENOV0.41x

IART0.60x

Revenue (TTM)

ENOV$2.30B

IART$1.66B

Revenue Growth (YoY)

ENOV4.9%

IART0.8%

Forward Rev Growth

ENOV4.9%

IART3.2%

Gross Margin (TTM)

ENOV61.4%

IART43.1%

Operating Margin (TTM)

ENOV0.0%

IART4.0%

EBITDA Margin (TTM)

ENOV16.9%

IART16.1%

Net Margin (TTM)

ENOV-48.0%

IART-0.1%

FCF Margin (TTM)

ENOV2.8%

IART-0.9%

Net Income (TTM)

ENOV$-1.10B

IART$-2M

FCF (TTM)

ENOV$64M

IART$-14M

EPS (TTM)

ENOV-$19.13

IART$0.00

ROE (TTM)

ENOV-6817.0%

IART-70.0%

ROA (TTM)

ENOV-2777.0%

IART-20.0%

ROIC (TTM)

ENOV-3756.0%

IART-25.0%

Cash

ENOV$13M

IART$0

Debt

ENOV$1.28B

IART$0

Net Cash/Debt

ENOV$-1.27B

IART$0

Current Ratio (TTM)

ENOV1.98x

IART3.60x

Quick Ratio (TTM)

ENOV0.92x

IART1.80x

Debt/Equity (TTM)

ENOV0.87x

IART1.79x

Debt/Assets (TTM)

ENOV0.0%

IART0.0%

Interest Coverage (TTM)

ENOVN/A

IARTN/A

Net Debt/EBITDA (TTM)

ENOV0.00x

IART0.00x

Beta

ENOV1.45

IART1.27

52W Performance

ENOV-44.3%

IART-9.3%

YTD Performance

ENOV-33.3%

IART11.9%

% from 52W High

ENOV-48.4%

IART-34.4%

% from 52W Low

ENOV5.9%

IART54.5%

Asset Turnover (TTM)

ENOV0.58x

IART0.46x

FCF Yield (TTM)

ENOV6.3%

IART-1.4%

Earnings Yield (TTM)

ENOV-108.2%

IART-0.2%

Dividend Yield (TTM)

ENOVN/A

IARTN/A

Rule of 40

ENOV7.7

IART-0.0

EV/GP/RG

ENOV0.19

IART0.26

Ticker research

View ENOV research View IART research

Metric	ENOV Enovis Corp	IART Integra Lifesciences Holdings Corp
Market & Valuation
Market Cap	$1.02B	$1.05B
Enterprise Value	$2.29B	$1.05B
Price	$17.69	$13.44
P/E Ratio	N/A	N/A
P/S Ratio	0.44x	0.63x
EV/Sales	1.00x	0.63x
EV/EBITDA	5.92x	3.92x
P/B Ratio	0.69x	0.95x
P/FCF Ratio	16.00x	N/A
EV/FCF	35.98x	-73.87x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.57x	4.99x
Forward P/S (NTM)	0.41x	0.60x
Revenue & Growth
Revenue (TTM)	$2.30B	$1.66B
Revenue Growth (YoY)	4.9%	0.8%
Forward Rev Growth	4.9%	3.2%
Profitability
Gross Margin (TTM)	61.4%	43.1%
Operating Margin (TTM)	0.0%	4.0%
EBITDA Margin (TTM)	16.9%	16.1%
Net Margin (TTM)	-48.0%	-0.1%
FCF Margin (TTM)	2.8%	-0.9%
Net Income (TTM)	$-1.10B	$-2M
FCF (TTM)	$64M	$-14M
EPS (TTM)	-$19.13	$0.00
ROE (TTM)	-6817.0%	-70.0%
ROA (TTM)	-2777.0%	-20.0%
ROIC (TTM)	-3756.0%	-25.0%
Financial Health
Cash	$13M	$0
Debt	$1.28B	$0
Net Cash/Debt	$-1.27B	$0
Current Ratio (TTM)	1.98x	3.60x
Quick Ratio (TTM)	0.92x	1.80x
Debt/Equity (TTM)	0.87x	1.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.27
52W Performance	-44.3%	-9.3%
YTD Performance	-33.3%	11.9%
% from 52W High	-48.4%	-34.4%
% from 52W Low	5.9%	54.5%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.46x
FCF Yield (TTM)	6.3%	-1.4%
Earnings Yield (TTM)	-108.2%	-0.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.7	-0.0
EV/GP/RG	0.19	0.26
Ticker research	View ENOV research	View IART research